Abnormal serum hormone levels in lung cancer

Area of Science:

• Endocrinology
• Oncology
• Pulmonology

Background:

• Hormonal imbalances can be associated with various diseases, including cancer.
• Lung cancer patients may exhibit altered levels of reproductive and pituitary hormones.

Purpose of the Study:

• To investigate serum levels of human chorionic gonadotropin (HCG), testosterone, luteinizing hormone (LH), and prolactin in lung cancer patients.
• To compare hormone levels between lung cancer patients, benign lung disease patients, and healthy controls.
• To explore correlations between hormone levels and lung cancer histology and stage.

Main Methods:

• Radioimmunoassay was used to measure serum hormone levels.
• Study included 59 lung cancer patients, 10 benign lung disease patients, and 37 normal controls.
• Statistical analysis was performed to compare hormone levels across groups and correlate with disease characteristics.

Main Results:

• Human chorionic gonadotropin (HCG) was detected in 6.8% of lung cancer patients only.
• Prolactin and LH levels were significantly elevated in lung cancer and benign lung disease groups compared to controls.
• Testosterone levels were significantly lower in lung cancer patients, particularly those with small cell or squamous cell carcinoma, and those with lymph node metastases.

Conclusions:

• Elevated prolactin and LH may indicate pulmonary pathology, not exclusively neoplastic.
• Decreased testosterone levels are likely associated with the presence of a lung tumor.
• Hormonal profiling could offer insights into lung cancer pathophysiology and patient stratification.